ScripTiba, CEPI Strive To Plan Ahead For Next Pandemic Tiba Biotech LLC and CEPI (Coalition for Epidemic Preparedness Innovations) said on 12 January that they will partner to evaluate the Cambridge, M
ScripGermany’s BI Licenses Tumor-Specific Antibodies From Singapore Lab Boehringer Ingelheim GmbH and Singapore’s Agency for Science, Technology and Research (A*STAR) unveiled a global licensing agreem
ScripBiopharmaceutical companies raised $19.5bn in venture capital through the third quarter of 2020 and now Pitchbook and the National Venture Capital Association (NVCA) have revealed that the industry br
ScripVor Hopes NCI’s CAR-T Candidate Is Synergistic With Lead AML Therapy PureTech Health plc -backed Vor Biopharma Inc. said on 11 November that it has licensed a clinical-stage chimeric antigen recept